Related Experiment Video
Updated: May 8, 2026

09:26
Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication
Published on: February 6, 2019
Functional Neuroimaging of Cortical Dysfunction in Alcoholic Korsakoff's Syndrome
K A Paller1, A Acharya, B C Richardson
1Lawrence Berkeley National Laboratory and Northwestern University.
Journal of Cognitive Neuroscience
|August 22, 2013
Summary
Alcoholic Korsakoff's syndrome impairs delayed memory due to widespread brain metabolism decline, not just diencephalic damage. This suggests disrupted thalamocortical interactions contribute to memory loss in these patients.
Area of Science:
- Neuropsychology
- Neuroimaging
- Cognitive Neuroscience
Background:
- Alcoholic Korsakoff's syndrome is characterized by amnesic deficits.
- Structural neuroimaging implicates midline diencephalic damage, but functional deficits remain unclear.
Purpose of the Study:
- To investigate regional cerebral metabolic rates for glucose utilization in alcoholic Korsakoff patients using PET.
- To explore the neuropathology contributing to cognitive dysfunction in Korsakoff's syndrome.
Main Methods:
- High-resolution positron emission tomography (PET) was employed.
- Regional cerebral metabolic rates for glucose utilization were measured.
- Subjects included five alcoholic Korsakoff patients and nine alcoholic controls.
Main Results:
- Korsakoff patients showed normal immediate memory but impaired delayed recognition.
- PET revealed widespread glucose metabolism decline in frontal, parietal, and cingulate regions in Korsakoff patients.
- Hippocampal glucose metabolism did not differ between groups.
Conclusions:
- The findings suggest widespread cerebral cortical dysfunction contributes to memory impairment in Korsakoff's syndrome.
- Evidence does not support parallel brain dysfunctions after hippocampal and diencephalic damage.
- A disruption of thalamocortical interactions is hypothesized to underlie Korsakoff's syndrome amnesia.
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
